J&J CEO: Some Cancers Could Be Cured Within a Decade

Johnson & Johnson's CEO said June 10 that curing certain cancers—or turning them into manageable chronic diseases—is scientifically plausible within ten years. J&J's cancer pipeline uses targeted antibodies and CAR-T cell therapies showing strong response rates in multiple myeloma and lung cancer. The claim matters for investors, but whether the clinical data actually supports a decade timeline remains unclear.